Abstract
Two new docking programs FRED (OpenEye Scientific Software) and Glide (Schrödinger, Inc.) in combination with various scoring functions implemented in these programs have been evaluated against a variety of seven protein targets (cyclooxygenase-2, estrogen receptor, p38 MAP kinase, gyrase B, thrombin, gelatinase A, neuraminidase) in order to assess their accuracy in virtual screening. Sets of known inhibitors were added to and ranked relative to a random library of drug-like compounds. Performance was compared in terms of enrichment factors and CPU time consumption. Results and specific features of the two new tools are discussed and compared to previously published results using FlexX (Tripos, Inc.) as a docking engine. In addition, general criteria for the selection of docking algorithms and scoring functions based on binding-site characteristics of specific protein targets are proposed.
Figure Enrichment factors obtained with FlexX, Glide and FRED docking engines in combination with different scoring functions for seven selected targets with highly variable binding sites
Similar content being viewed by others
References
Bailey D, Brown D (2001) Drug Discovery Today 6:57–59
Walters WP, Stahl MT, Murcko MA (1998) Drug Discovery Today 3:160–178
Gane PJ, Dean PM (2000) Curr Opin Struct Biol 10:401–404
Good A (2001) Curr Opin Drug Disc Dev 4:301–307
Dixon JS, Blaney JM (1998) Docking—predicting the structure and binding affinity of ligand–receptor complexes in designing bioactive molecules. In: Martin YC, Willet P (eds) American Chemical Society, Washington, D.C., pp 175–197
Stahl M (2000) Structure-based library design in virtual screening for bioactive molecules. In: Schneider G, Boehm H-J (eds) Virtual screening for bioactive molecules. VCH, Weinheim, pp 229–259
Muegge I, Rarey M (2001) Small molecule docking and scoring. In Lipkowitz KB, Boyd DB (eds) Reviews in computational chemistry. VCH, New York, p 1
Burkhard P, Hommel U, Sanner M, Walkinshaw MD (1999) J Mol Biol 287:853–858
Filikov AV, Monan V, Vickers TA, Griffey RH, Cook PD, Abagyan RA, James TL (2000) J Comput-Aided Mol Design 14:593–610
Jordan DB, Basarab GS, Liao D-I, Johnson WMP, Winzenberg KN, Winkler DA (2001) J Mol Graphics Mod 19:434–447
Liebeschuetz JW, Jones SD, Morgan PJ, Murray CW, Rimmer AD, Roscoe JME, Waszkowycz B, Welsh PM, Wylie WA, Young SC, Martin H, Mahler J, Brady L, Wilkinson K (2002) J Med Chem 45:1221–1232
Ajay Murcko MA (1995) J Med Chem 38:4953–4967
Tame JRH (1999) J Comput–Aided Mol Design 13:99–108
Boehm H-J, Stahl M (1999) Med Chem Res 9:445–462
Gohlke H, Klebe G (2001) Curr Opin Struct Biol 11:231–235
Vieth M, Hirst JD, Dominy BN, Daigler H, Brooks III CL (1998) J Comput Chem 14:1623–1631
Abagyan R, Trotov M, Kuznetsov DJ (1994) Comput Chem 15:488–506
Morris GM, Goodsell DS, Huey R, Olson AJ (1996) J Comput–Aided Mol Design 10:293–304
Jones G, Willett P, Glen RC, Leach AR, Taylor R (1997) J Mol Biol 267:727–748
Stahl M, Rarey M (2001) J Med Chem 44:1035–1042
Muegge I, Martin YC (1999) J Med Chem 42:791–804
Gohlke H, Hendlich M, Klebe G (2000) J Mol Biol 295:337–356
Gehlhaar DK, Verkhivker GM, Rejto PA, Sherman CJ, Fogel DB, Fogel LJ, Freer ST (1995) Chem Biol 2:317–324
F. Brown, A. Nicholls, H. Almond, M. McGann (manuscript submitted)
Eldridge MD, Murray CW, Auton TR, Paolini GV, Mee RP (1997) J Comput-Aided Mol Design 11:425–445
Baxter CA, Murray CW, Clark DE, Westhead DR, Eldridge MD (1998) Proteins 33:367–382
Rarey M, Wefing S, Lengauer T (1996) J Comput-Aided Mol Design 10:41–54
Salo J–P, Yliniemelä A, Taskinen J (1998) J Chem Inf Comput Sci 38:832–839
Charifson PS, Corkery JJ, Murcko MA, Walters WP (1999) J Med Chem 42:5100–5109
Bissantz C, Folkers G, Rognan D (2000) J Med Chem 43:4759–4767
Rarey M, Kramer B, Lengauer T, Klebe G (1996) J Mol Biol 261:470–489
Rarey M, Kramer B, Lengauer T (1997) J Comput-Aided Mol Design 11:369–384
Rarey M, Kramer B, Lengauer T (1999) Bioinformatics 15:243–250
Moloc (2002) F Hoffmann-La Roche/Gerber Molecular Design
Sunderarm V, Dongarra J, Geist A, Manchek R (1994) Parallel Computing 20:531–547
http://www.epm.ornl.gov/pvm/pvm_home.html
Hindle SA, Rarey M, Buning C, Lengauer T (2002) J Comput-Aided Mol Design (in press)
Carter JS (1997) Exp Opin Ther Patents 8:21–29
Friesen RW, Brideau C, Chan CC, Charleson S, Deschenes D, Dubé D, Ethier D, Fortin R, Gauthier JY, Girard Y, Gordon R, Greig GM, Riendau D, Savoie C, Wang Z, Wong E, Visco D, Xu LJ, Young RN (1998) Bioorg Med Chem Lett 8:2777–2782
Kalgutkar AS (1999) Exp Opin Ther Patents 9:831–849
http://www.protherics.com/
Magarian RA, Overacre LB, Singh S, Meyer KL (1994) Curr Med Chem 1:61–104
Fink BE, Mortensen DS, Stauffer SR, Zachary DA, Katzenellenbogen JA (1999) Chem Biol 6:205–219
Hanson GJ (1997) Exp Opin Ther Patents 7:729–733
Wiley MR, Fisher MJ (1997) Exp Opin Ther Patents 7:1265–1282
Sanderson PEJ, Nayor–Olsen AM (1998) Curr Med Chem 5:289–304
Beckett RP, Whittaker M (1998) Exp Opin Ther Patents 8:259–282
Acknowledgements
The authors thank Tom Halgren from Schrödinger Inc. for providing Glide evaluation licenses and many discussions about this software, Jörg Weiser and Gerd Räther from Anterio Consult & Research for support, Anthony Nicholls, Matt Stahl and Mark McGann from OpenEye Software for providing FRED and OMEGA evaluation licenses and the implementation of ScreenScore into FRED. Matthias Rarey is thanked for his continuing support of FlexX and many fruitful discussions. We thank our colleagues at Roche Basel and in the Roche biostructure community for supporting our work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schulz-Gasch, T., Stahl, M. Binding site characteristics in structure-based virtual screening: evaluation of current docking tools. J Mol Model 9, 47–57 (2003). https://doi.org/10.1007/s00894-002-0112-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00894-002-0112-y